PART I Overview We are a commercial stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. We launched XDEMVY (lotilaner ophthalmic solution) 0.25%, formerly known as TP-03, for the treatment of Demodex blepharitis, in August 2023 after receiving U.S. Food and Drug Administration (FDA) approval in July 2023. Demodex blepharitis is caused by the infestation of Demodex mites. Demodex blepharitis (blephar is a reference to eyelid an...
expected 2026-11-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001819790-26-000019 | EDGAR | 107K words |
| 2025-02-25 | 2024-12-31 | 0001819790-25-000011 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0001819790-24-000018 | EDGAR | — |
| 2023-03-17 | 2022-12-31 | 0001819790-23-000007 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0001819790-22-000010 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001819790-21-000010 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001819790-26-000064 | EDGAR | — |
| 2025-11-04 | 2025-09-30 | 0001819790-25-000121 | EDGAR | 75K words |
| 2025-08-06 | 2025-06-30 | 0001819790-25-000108 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0001819790-25-000078 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001819790-24-000129 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001819790-24-000111 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001819790-24-000063 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001819790-23-000080 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001819790-23-000071 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001819790-23-000030 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001819790-22-000042 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001819790-22-000030 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001819790-26-000063 | EDGAR | — |
| 2026-08-06 | 0001819790-26-000062 | EDGAR | — |
| 2026-08-06 | 0001819790-26-000060 | EDGAR | — |
| 2026-07-13 | 0001819790-26-000048 | EDGAR | — |
| 2026-02-23 | 0001819790-26-000017 | EDGAR | 4K words |
| 2026-02-18 | 0001819790-26-000005 | EDGAR | — |
| 2026-01-12 | 0001819790-26-000002 | EDGAR | — |
| 2025-11-04 | 0001819790-25-000120 | EDGAR | — |
| 2025-08-06 | 0001819790-25-000107 | EDGAR | — |
| 2025-06-18 | 0001819790-25-000100 | EDGAR | — |
106 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001819790 |
| Ticker | TARS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.tarsusrx.com |
| Listed | 2020-10-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TARS (~200 tokens, structured JSON with cryptographic provenance)